Usage	0	4
of	6	7
signaling	9	17
in	19	20
neurodegeneration	22	38
and	40	42
regeneration	44	55
of	57	58
peripheral	60	69
nerves	71	76
by	78	79
leprosy	81	87
bacteria	89	96
.	97	97

Multiple	99	106
signaling	108	116
pathways	118	125
play	127	130
key	132	134
regulatory	136	145
roles	147	151
during	153	158
the	160	162
development	164	174
of	176	177
peripheral	179	188
nervous	190	196
system	198	203
(	205	205
PNS	206	208
)	209	209
and	211	213
also	215	218
in	220	221
neuroregeneration	223	239
process	241	247
following	249	257
nerve	259	263
degeneration	265	276
.	277	277

Schwann	279	285
cells	287	291
,	292	292
the	294	296
glial	298	302
cells	304	308
of	310	311
the	313	315
PNS	317	319
,	320	320
by	322	323
interacting	325	335
with	337	340
neuronal	342	349
(	351	351
axonal	352	357
)	358	358
ligands	360	366
,	367	367
mainly	369	374
neuregulins	376	386
via	388	390
receptor	392	399
tyrosine	401	408
kinase	410	415
(	417	417
RTK	418	420
)	421	421
complex	423	429
,	430	430
ErbB2	432	436
/	437	437
ErbB3	438	442
,	443	443
initiate	445	452
intracellular	454	466
signaling	468	476
pathways	478	485
to	487	488
drive	490	494
proliferation	496	508
and	510	512
differentiation	514	528
of	530	531
Schwann	533	539
cells	541	545
,	546	546
both	548	551
during	553	558
development	560	570
and	572	574
the	576	578
process	580	586
of	588	589
regeneration	591	602
and	604	606
re	608	609
-	610	610
myelination	611	621
after	623	627
nerve	629	633
injury	635	640
.	641	641

One	643	645
of	647	648
the	650	652
major	654	658
signaling	660	668
kinases	670	676
,	677	677
extracellular	679	691
signal	693	698
-	699	699
regulated	700	708
kinase	710	715
-	716	716
1	717	717
/	718	718
2	719	719
(	721	721
ERK1	722	725
/	726	726
2	727	727
)	728	728
,	729	729
that	731	734
is	736	737
also	739	742
a	744	744
downstream	746	755
signaling	757	765
pathway	767	773
of	775	776
neuregulin	778	787
-	788	788
ErbB2	789	793
/	794	794
ErbB3	795	799
activation	801	810
,	811	811
has	813	815
been	817	820
identified	822	831
as	833	834
a	836	836
key	838	840
regulator	842	850
of	852	853
Schwann	855	861
cell	863	866
proliferation	868	880
,	881	881
differentiation	883	897
,	898	898
demyelination	900	912
and	914	916
nerve	918	922
regeneration	924	935
.	936	936

Recent	938	943
studies	945	951
have	953	956
provided	958	965
evidence	967	974
that	976	979
the	981	983
bacterium	985	993
that	995	998
causes	1000	1005
human	1007	1011
leprosy	1013	1019
,	1020	1020
Mycobacterium	1022	1034
leprae	1036	1041
that	1043	1046
has	1048	1050
a	1052	1052
unique	1054	1059
capacity	1061	1068
to	1070	1071
invade	1073	1078
Schwann	1080	1086
cells	1088	1092
of	1094	1095
the	1097	1099
adult	1101	1105
PNS	1107	1109
,	1110	1110
utilizes	1112	1119
the	1121	1123
neuregulin	1125	1134
-	1135	1135
ErbB2	1136	1140
/	1141	1141
ErbB3	1142	1146
associated	1148	1157
signaling	1159	1167
network	1169	1175
to	1177	1178
the	1180	1182
bacterial	1184	1192
advantage	1194	1202
.	1203	1203

M	1205	1205
.	1206	1206
leprae	1208	1213
directly	1215	1222
bind	1224	1227
to	1229	1230
ErbB2	1232	1236
on	1238	1239
myelinated	1241	1250
Schwann	1252	1258
cells	1260	1264
and	1266	1268
activate	1270	1277
the	1279	1281
RTK	1283	1285
by	1287	1288
a	1290	1290
novel	1292	1296
route	1298	1302
that	1304	1307
bypasses	1309	1316
the	1318	1320
classical	1322	1330
neuregulin	1332	1341
/	1342	1342
growth	1343	1348
factor	1350	1355
-	1356	1356
induced	1357	1363
ErbB2	1365	1369
-	1370	1370
ErbB3	1371	1375
heterodimerization	1377	1394
,	1395	1395
and	1397	1399
subsequently	1401	1412
induce	1414	1419
downstream	1421	1430
the	1432	1434
canonical	1436	1444
Erk1	1446	1449
/	1450	1450
2	1451	1451
signaling	1453	1461
,	1462	1462
leading	1464	1470
to	1472	1473
myelin	1475	1480
breakdown	1482	1490
and	1492	1494
subsequent	1496	1505
axonal	1507	1512
damage	1514	1519
.	1520	1520

This	1522	1525
initial	1527	1533
injury	1535	1540
provides	1542	1549
a	1551	1551
survival	1553	1560
advantage	1562	1570
for	1572	1574
M	1576	1576
.	1577	1577
leprae	1579	1584
as	1586	1587
it	1589	1590
induces	1592	1598
de	1600	1601
-	1602	1602
differentiation	1603	1617
and	1619	1621
generates	1623	1631
myelin	1633	1638
-	1639	1639
free	1640	1643
cells	1645	1649
,	1650	1650
which	1652	1656
are	1658	1660
highly	1662	1667
susceptible	1669	1679
to	1681	1682
M	1684	1684
.	1685	1685
leprae	1687	1692
invasion	1694	1701
and	1703	1705
promote	1707	1713
bacterial	1715	1723
survival	1725	1732
.	1733	1733

Once	1735	1738
invaded	1740	1746
M	1748	1748
.	1749	1749
leprae	1751	1756
activate	1758	1765
Erk1	1767	1770
/	1771	1771
2	1772	1772
via	1774	1776
a	1778	1778
non	1780	1782
-	1783	1783
canonical	1784	1792
pathway	1794	1800
and	1802	1804
subsequently	1806	1817
increase	1819	1826
the	1828	1830
cell	1832	1835
proliferation	1837	1849
and	1851	1853
maintain	1855	1862
the	1864	1866
infected	1868	1875
cells	1877	1881
in	1883	1884
de	1886	1887
-	1888	1888
differentiated	1889	1902
state	1904	1908
,	1909	1909
thereby	1911	1917
preventing	1919	1928
remyelination	1930	1942
.	1943	1943

Therefore	1945	1953
,	1954	1954
by	1956	1957
subverting	1959	1968
major	1970	1974
RTKs	1976	1979
and	1981	1983
signaling	1985	1993
pathways	1995	2002
in	2004	2005
adult	2007	2011
Schwann	2013	2019
cells	2021	2025
M	2027	2027
.	2028	2028
leprae	2030	2035
appear	2037	2042
to	2044	2045
propagate	2047	2055
the	2057	2059
bacterial	2061	2069
niche	2071	2075
and	2077	2079
maintain	2081	2088
survival	2090	2097
within	2099	2104
the	2106	2108
PNS	2110	2112
.	2113	2113

These	2115	2119
studies	2121	2127
may	2129	2131
also	2133	2136
provide	2138	2144
new	2146	2148
insights	2150	2157
into	2159	2162
our	2164	2166
understanding	2168	2180
of	2182	2183
signaling	2185	2193
mechanisms	2195	2204
involve	2206	2212
in	2214	2215
both	2217	2220
neurodegeneration	2222	2238
and	2240	2242
neuroregeneration	2244	2260
.	2261	2261
